Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 72 of 72 entries
View as:

Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02932462 Org: User:
Start: 03/31/16 End: 09/29/17 Due: 09/29/18

T2000 in Essential Tremor - Open Label Continuation

Phase: N/A Priority: Normal
NCT ID: NCT00655278 Org: User:
Start: 08/31/07 End: 12/31/09 Due: 12/31/10

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03132194 Org: User:
Start: 08/08/16 End: 01/30/17 Due: 01/30/18

An Open-Label Study to Assess Safety

Phase: N/A Priority: Normal
NCT ID: NCT03645499 Org: User:
Start: 04/04/18 End: 01/07/20 Due: 01/07/21

Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02340169 Org: User:
Start: 01/23/15 End: 11/22/21 Due: 11/22/22

A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.

Phase: N/A Priority: Normal
NCT ID: NCT06673641 Org: User:
Start: 05/13/24 End: 09/03/24 Due: 09/03/25

A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT02413229 Org: User:
Start: 04/30/15 End: 01/29/16 Due: 01/29/17

Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT02933879 Org: User:
Start: 03/21/16 End: 06/21/18 Due: 06/21/19

Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02595008 Org: User:
Start: 08/28/15 End: 08/25/17 Due: 08/25/18

A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01769664 Org: User:
Start: 09/30/12 End: 08/31/13 Due: 08/31/14

A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions.

Phase: N/A Priority: Normal
NCT ID: NCT01876550 Org: User:
Start: 02/28/13 End: 05/06/19 Due: 05/06/20

Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study

Phase: N/A Priority: Normal
NCT ID: NCT01018134 Org: User:
Start: 11/30/09 End: 05/31/10 Due: 05/31/11

A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.

Phase: N/A Priority: Normal
NCT ID: NCT06673654 Org: User:
Start: 08/11/23 End: 09/23/24 Due: 09/23/25

A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.

Phase: N/A Priority: Normal
NCT ID: NCT05282771 Org: User:
Start: 04/16/21 End: 02/10/22 Due: 02/10/23

Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01769235 Org: User:
Start: 11/30/12 End: 12/31/13 Due: 12/31/14

Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Patients With Interdigital Tinea Pedis

Phase: N/A Priority: Normal
NCT ID: NCT01119742 Org: User:
Start: 07/31/10 End: 07/31/11 Due: 07/31/12

Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice

Phase: N/A Priority: Normal
NCT ID: NCT00244439 Org: User:
Start: 12/31/05 End: 12/31/06 Due: 12/31/07

A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02411955 Org: User:
Start: 06/30/14 End: 02/28/15 Due: 02/28/16

A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.

Phase: N/A Priority: Normal
NCT ID: NCT06305637 Org: User:
Start: 12/04/23 End: 02/10/24 Due: 02/10/25

Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis

Phase: N/A Priority: Normal
NCT ID: NCT02132260 Org: User:
Start: 08/31/13 End: 03/31/14 Due: 03/31/15

Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT04321070 Org: User:
Start: 09/09/19 End: 03/06/20 Due: 03/06/21

Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00833079 Org: User:
Start: 10/31/08 End: 03/31/10 Due: 03/31/11